author-photo

John Sharpe

56

Papers

350

Citations

Citation Trend

Filter By

Papers (41) Sort By

Journal Conference Others

Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients

2020 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (5)
Review as a necessary ingredient in transitional change

2018
- Gilles Amado
- John Sharpe
Show All
- Source
- Cite
- Save
Citations (0)
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

2017 British Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (12)
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

2017
Show All
- Source
- Cite
- Save
Citations (0)
Ocular hypotensive effects and tolerability of the novel dual EP3/FP receptor agonist ONO-9054 vs. Xalatan®: Results of a 28 day, double masked, randomized, active comparator study in open angle glaucoma (OAG) and ocular hypertension (OHT)

2016 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (2)
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

2016
Show All
- Source
- Cite
- Save
Citations (1)
Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women

2015 Journal of Bone and Mineral Metabolism
Show All
- Source
- Cite
- Save
Citations (9)
Mo1287 Efficacy of ONO-2952, a Novel and Selective Antagonist of Translocator Protein: Results of a Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase II Study (RESTORE-4)

2015 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
The Bruton’s Tyrosine Kinase (BTK) Inhibitor ONO-4059: Promising Single Agent Activity and Well Tolerated in Patients with High Risk Chronic Lymphocytic Leukaemia (CLL)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Humanism & Excellence in Teaching Award

2013
Show All
- Source
- Cite
- Save
Citations (0)